Guy Makin

2.4k total citations
49 papers, 1.8k citations indexed

About

Guy Makin is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Guy Makin has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Neurology and 14 papers in Oncology. Recurrent topics in Guy Makin's work include Neuroblastoma Research and Treatments (21 papers), Cancer therapeutics and mechanisms (12 papers) and Cell death mechanisms and regulation (10 papers). Guy Makin is often cited by papers focused on Neuroblastoma Research and Treatments (21 papers), Cancer therapeutics and mechanisms (12 papers) and Cell death mechanisms and regulation (10 papers). Guy Makin collaborates with scholars based in United Kingdom, United States and France. Guy Makin's co-authors include Caroline Dive, John A. Hickman, Rebecca Ray, David Lohnes, Valarie Byford, Glenville Jones, Muhammad H. Zaman, Deema Hussein, Edward J. Estlin and Andrew Price and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Guy Makin

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Makin United Kingdom 23 969 537 375 260 236 49 1.8k
Xiaobing Deng United States 24 1.2k 1.2× 436 0.8× 300 0.8× 99 0.4× 64 0.3× 39 1.8k
Zebin Wang China 19 1.5k 1.5× 692 1.3× 659 1.8× 205 0.8× 50 0.2× 49 2.2k
Angelina V. Vaseva United States 16 1.4k 1.5× 605 1.1× 328 0.9× 118 0.5× 50 0.2× 25 1.9k
Zhenhua Lin China 30 1.7k 1.7× 536 1.0× 380 1.0× 142 0.5× 53 0.2× 90 2.3k
Aruna Basu United States 19 1.2k 1.2× 690 1.3× 234 0.6× 176 0.7× 49 0.2× 23 1.9k
Fan Feng China 26 945 1.0× 334 0.6× 625 1.7× 183 0.7× 44 0.2× 66 1.8k
Gabriel Pons Spain 23 1.3k 1.4× 427 0.8× 250 0.7× 261 1.0× 46 0.2× 60 2.1k
Michihiko Wada Japan 26 1.1k 1.1× 1.1k 2.1× 459 1.2× 110 0.4× 72 0.3× 58 2.4k
Honyin Chiu United States 6 1.3k 1.3× 400 0.7× 318 0.8× 196 0.8× 44 0.2× 7 2.0k
Wolfram C. M. Dempke Germany 20 727 0.8× 727 1.4× 258 0.7× 136 0.5× 73 0.3× 48 1.8k

Countries citing papers authored by Guy Makin

Since Specialization
Citations

This map shows the geographic impact of Guy Makin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Makin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Makin more than expected).

Fields of papers citing papers by Guy Makin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Makin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Makin. The network helps show where Guy Makin may publish in the future.

Co-authorship network of co-authors of Guy Makin

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Makin. A scholar is included among the top collaborators of Guy Makin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Makin. Guy Makin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geoerger, Birgit, Lynley V. Marshall, Karsten Nysom, et al.. (2023). Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial. European Journal of Cancer. 188. 8–19. 3 indexed citations
2.
Casanova, Michela, Francisco Bautista, Guy Makin, et al.. (2023). Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study. Clinical Cancer Research. 29(21). 4341–4351. 19 indexed citations
3.
Barnett, S., Guy Makin, Deborah A. Tweddle, Caroline Osborne, & Gareth J. Veal. (2023). Generation of evidence-based carboplatin dosing guidelines for neonates and infants. British Journal of Cancer. 129(11). 1773–1779. 4 indexed citations
4.
Hussein, Deema, Mohamad Saka, Chris Stride, et al.. (2021). The efficacy of interactive group psychoeducation for children with leukaemia: A randomised controlled trial. Patient Education and Counseling. 104(12). 3008–3015. 1 indexed citations
5.
Barnett, S., Guy Makin, Deborah A. Tweddle, et al.. (2021). Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients. European Journal of Cancer. 164. 127–136. 22 indexed citations
6.
Chen, Lindi, Mark Brougham, Guy Makin, et al.. (2019). Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers. Clinical Cancer Research. 26(1). 122–134. 29 indexed citations
7.
Bate, Jessica, Stephen Baker, Judith Breuer, et al.. (2018). PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Archives of Disease in Childhood. 104(1). 25–29. 7 indexed citations
8.
Amoroso, Loredana, Giovanni Erminio, Guy Makin, et al.. (2017). Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study. Cancer Research and Treatment. 50(1). 148–155. 39 indexed citations
9.
Basta, Nermine O., Guy Makin, Jillian M. Birch, et al.. (2016). Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. British Journal of Cancer. 115(9). 1048–1057. 61 indexed citations
10.
Moreno, Lucas, Lynley V. Marshall, Andrew D.J. Pearson, et al.. (2014). A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study. Clinical Cancer Research. 21(2). 267–273. 39 indexed citations
11.
Price, Andrew, et al.. (2013). Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha. PLoS ONE. 8(6). e65304–e65304. 63 indexed citations
12.
Villa, Shaun, et al.. (2012). Alteration of Cellular Behavior and Response to PI3K Pathway Inhibition by Culture in 3D Collagen Gels. PLoS ONE. 7(10). e48024–e48024. 67 indexed citations
13.
Klymenko, Tetyana, et al.. (2011). The Novel Bcl-2 Inhibitor ABT-737 Is More Effective in Hypoxia and Is Able to Reverse Hypoxia-Induced Drug Resistance in Neuroblastoma Cells. Molecular Cancer Therapeutics. 10(12). 2373–2383. 26 indexed citations
14.
Micha, Dimitra, Kathryn Simpson, Christopher J. Morrow, et al.. (2011). Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1. Journal of Clinical Investigation. 121(3). 1075–1087. 48 indexed citations
15.
Dean, Emma, Timothy H. Ward, Clemencia Pinilla, et al.. (2009). A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. British Journal of Cancer. 102(1). 97–103. 35 indexed citations
16.
Holt, Sarah V., et al.. (2007). Downregulation of XIAP expression induces apoptosis and sensitizes a panel of pediatric tumor cells to cytotoxic agents. Molecular Cancer Therapeutics. 6. 1 indexed citations
17.
Makin, Guy. (2002). Targeting apoptosis in cancer chemotherapy. Expert Opinion on Therapeutic Targets. 6(1). 73–84. 37 indexed citations
18.
19.
Makin, Guy & John A. Hickman. (2000). Apoptosis and cancer chemotherapy. Cell and Tissue Research. 301(1). 143–152. 188 indexed citations
20.
Arkwright, Peter D., Guy Makin, Andrew Will, et al.. (1998). X linked lymphoproliferative disease in a United Kingdom family. Archives of Disease in Childhood. 79(1). 52–55. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaobing Deng Breakdown of academic impact, for papers by Zebin Wang Breakdown of academic impact, for papers by Angelina V. Vaseva Breakdown of academic impact, for papers by Zhenhua Lin Breakdown of academic impact, for papers by Aruna Basu Breakdown of academic impact, for papers by Fan Feng Breakdown of academic impact, for papers by Gabriel Pons Breakdown of academic impact, for papers by Michihiko Wada Breakdown of academic impact, for papers by Honyin Chiu Breakdown of academic impact, for papers by Wolfram C. M. Dempke
Rankless by CCL
2026